JPH033679B2 - - Google Patents
Info
- Publication number
- JPH033679B2 JPH033679B2 JP57142213A JP14221382A JPH033679B2 JP H033679 B2 JPH033679 B2 JP H033679B2 JP 57142213 A JP57142213 A JP 57142213A JP 14221382 A JP14221382 A JP 14221382A JP H033679 B2 JPH033679 B2 JP H033679B2
- Authority
- JP
- Japan
- Prior art keywords
- dione
- methyl
- pregnadiene
- dihydroxy
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 claims abstract description 19
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 9
- 150000001885 cortisol derivatives Chemical class 0.000 claims abstract description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 8
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 5
- -1 (3-methoxypropionyloxy)-1,4-pregnadiene-3,20-dione Chemical compound 0.000 claims description 13
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 3
- FPKPFQURCPYZFH-PPJDWOAVSA-N [(6s,8s,9s,10r,11s,13s,14s,17r)-17-(2-acetyloxyacetyl)-11-hydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-yl] 2-ethoxyacetate Chemical compound C1([C@@H](C)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@](C(=O)COC(C)=O)(OC(=O)COCC)[C@@]2(C)C[C@@H]1O FPKPFQURCPYZFH-PPJDWOAVSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- GUHFLRTWNHWJBS-VLTGGNAYSA-N (8r,9s,10s,13s)-17-acetyl-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C1CC2CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1C1=CC=C(C(=O)C)[C@@]1(C)CC2 GUHFLRTWNHWJBS-VLTGGNAYSA-N 0.000 claims 1
- AEFWIIUGQGWQEN-HUCUVGNTSA-N [2-[(6s,8s,9s,10r,11s,13s,14s,17r)-11-hydroxy-17-(2-methoxyacetyl)oxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanoate Chemical compound C1([C@@H](C)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](OC(=O)COC)(C(=O)COC(=O)CCC)[C@@]2(C)C[C@@H]1O AEFWIIUGQGWQEN-HUCUVGNTSA-N 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 22
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 21
- 238000002844 melting Methods 0.000 description 20
- 230000008018 melting Effects 0.000 description 20
- 239000000243 solution Substances 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 229910052744 lithium Inorganic materials 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 7
- 239000012043 crude product Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- JJKWHOSQTYYFAE-UHFFFAOYSA-N 2-methoxyacetyl chloride Chemical compound COCC(Cl)=O JJKWHOSQTYYFAE-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- ZPMWWAIBJJFPPQ-UHFFFAOYSA-N 2-ethoxyacetyl chloride Chemical compound CCOCC(Cl)=O ZPMWWAIBJJFPPQ-UHFFFAOYSA-N 0.000 description 3
- JSMDUOFOPDSKIQ-UHFFFAOYSA-N 3-methoxypropanoyl chloride Chemical compound COCCC(Cl)=O JSMDUOFOPDSKIQ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- QBERHIJABFXGRZ-UHFFFAOYSA-M rhodium;triphenylphosphane;chloride Chemical compound [Cl-].[Rh].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 QBERHIJABFXGRZ-UHFFFAOYSA-M 0.000 description 3
- GFXIPEXVMCDDBA-UHFFFAOYSA-N 3-ethoxypropanoyl chloride Chemical compound CCOCCC(Cl)=O GFXIPEXVMCDDBA-UHFFFAOYSA-N 0.000 description 2
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- VNYXWHQJKOPMMK-YPYQNWSCSA-N [(6s,8s,9s,10r,11s,13s,14s,17r)-17-(2-acetyloxyacetyl)-11-hydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-yl] 2-methoxyacetate Chemical compound C1([C@@H](C)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@](C(=O)COC(C)=O)(OC(=O)COC)[C@@]2(C)C[C@@H]1O VNYXWHQJKOPMMK-YPYQNWSCSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- KRWRKBGCHCCZGL-KXSVHEDMSA-N (6S,8S,9S,10R,13S,14S,17S)-17-(2,2-dihydroxyacetyl)-6,10,13-trimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one Chemical compound OC(C([C@H]1CC[C@H]2[C@@H]3C[C@@H](C4=CC(C=C[C@]4(C)[C@H]3CC[C@]12C)=O)C)=O)O KRWRKBGCHCCZGL-KXSVHEDMSA-N 0.000 description 1
- RIBKERFYIKLVJY-JTJRRIIFSA-N (6S,8S,9S,10R,13S,14S,17S)-17-(2-hydroxyacetyl)-6,10,13-trimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C[C@H]1C[C@H]2[C@@H]3CC[C@H](C(CO)=O)[C@]3(CC[C@@H]2[C@]2(C=CC(C=C12)=O)C)C RIBKERFYIKLVJY-JTJRRIIFSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- 206010068172 Anal pruritus Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 208000009544 Pruritus Ani Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- JQNFMYSMWJHGNP-YPYQNWSCSA-N [(6s,8s,9s,10r,11s,13s,14s,17r)-17-(2-acetyloxyacetyl)-11-hydroxy-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl] 2-methoxyacetate Chemical compound C1([C@@H](C)C2)=CC(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@](C(=O)COC(C)=O)(OC(=O)COC)[C@@]2(C)C[C@@H]1O JQNFMYSMWJHGNP-YPYQNWSCSA-N 0.000 description 1
- LCPQABKHQQGJFS-PPJDWOAVSA-N [(6s,8s,9s,10r,11s,13s,14s,17r)-17-(2-acetyloxyacetyl)-11-hydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-yl] 3-methoxypropanoate Chemical compound C1([C@@H](C)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@](C(=O)COC(C)=O)(OC(=O)CCOC)[C@@]2(C)C[C@@H]1O LCPQABKHQQGJFS-PPJDWOAVSA-N 0.000 description 1
- CJHMFROZFNZQQU-FZNHGJLXSA-N [(8s,9s,10r,11s,13s,14s,17r)-17-(2-acetyloxyacetyl)-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-yl] 2-methoxyacetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(C)=O)(OC(=O)COC)[C@@]1(C)C[C@@H]2O CJHMFROZFNZQQU-FZNHGJLXSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 208000004921 cutaneous lupus erythematosus Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- LSACYLWPPQLVSM-UHFFFAOYSA-N isobutyric acid anhydride Chemical compound CC(C)C(=O)OC(=O)C(C)C LSACYLWPPQLVSM-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 201000011486 lichen planus Diseases 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- RJKFOVLPORLFTN-UHFFFAOYSA-N progesterone acetate Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)C1(C)CC2 RJKFOVLPORLFTN-UHFFFAOYSA-N 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- QQZMDXUEROTLLD-UHFFFAOYSA-N rhodium;triphenylphosphane Chemical compound [Rh].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 QQZMDXUEROTLLD-UHFFFAOYSA-N 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
ãçºæã®è©³çްãªèª¬æã
æ¬çºæã¯äžè¬åŒ
ãåŒäžããã¯åçµååã¯äºéçµåã衚ãããïœã¯
æ°ïŒåã¯ïŒã衚ãããR1ã¯æ°ŽçŽ åååã¯ã¡ãã«
åºã衚ãããR2ã¯ççŽ ååæ°ïŒãïŒã®ã¢ã«ãã«
åºã衚ãããR3ã¯æ°ŽçŽ åååã¯ççŽ ååæ°ïŒã
ïŒã®ïŒâãªããœã¢ã«ãã«åºã衚ãããã®ãããã³
ãŒããŸã³èªå°äœåã³ãã®è£œæ³ã«é¢ããã
æ°ïŒåã¯ïŒã衚ãããR1ã¯æ°ŽçŽ åååã¯ã¡ãã«
åºã衚ãããR2ã¯ççŽ ååæ°ïŒãïŒã®ã¢ã«ãã«
åºã衚ãããR3ã¯æ°ŽçŽ åååã¯ççŽ ååæ°ïŒã
ïŒã®ïŒâãªããœã¢ã«ãã«åºã衚ãããã®ãããã³
ãŒããŸã³èªå°äœåã³ãã®è£œæ³ã«é¢ããã
äžè¬åŒã®æ°èŠãããã³ãŒããŸã³èªå°äœã¯ççŽ
ååæ°ïŒãïŒã®ïŒâãªããœã¢ã«ãã«åºR3ãšããŠ
äŸãã°ã¢ã»ãã«åºãããããªãã«åºããããªã«
åºãã€ãœãããªã«åºããã¬ãªã«åºãïŒâã¡ãã«ã
ããªã«åºãããªã¡ãã«ã¢ã»ãã«åºåã¯ãããµãã€
ã«åºãæããŠããŠããã
ååæ°ïŒãïŒã®ïŒâãªããœã¢ã«ãã«åºR3ãšããŠ
äŸãã°ã¢ã»ãã«åºãããããªãã«åºããããªã«
åºãã€ãœãããªã«åºããã¬ãªã«åºãïŒâã¡ãã«ã
ããªã«åºãããªã¡ãã«ã¢ã»ãã«åºåã¯ãããµãã€
ã«åºãæããŠããŠããã
ã¢ã«ãã«åºR2ãšããŠãäžè¬åŒã®ãããã³ãŒ
ããŸã³èªå°äœã¯äŸãã°ã¡ãã«åºããšãã«åºããã
ãã«åºãã€ãœãããã«åºãããã«åºãsecâãã
ã«åºãtertâããã«åºåã¯ãã³ãã«åºãæããã
ããŸã³èªå°äœã¯äŸãã°ã¡ãã«åºããšãã«åºããã
ãã«åºãã€ãœãããã«åºãããã«åºãsecâãã
ã«åºãtertâããã«åºåã¯ãã³ãã«åºãæããã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ã«èšèŒããããããã³ãŒ
ããŸã³èªå°äœã¯åŒ·åãªæ¶çäœçšãæããã
ããŸã³èªå°äœã¯åŒ·åãªæ¶çäœçšãæããã
å
šèº«æäžã«ãããŠã¯ããããã®ãããã³ãŒããŸ
ã³ã®èªå°äœã¯æ¯èŒç匱ãäœçšã瀺ãã
ã³ã®èªå°äœã¯æ¯èŒç匱ãäœçšã瀺ãã
åŸã€ãŠãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ã«ããäžè¬åŒ
ã®æ°èŠãããã³ãŒããŸã³èªå°äœã¯ã¬ãŒã¬ã³åŒè£œå€
ã«ãããŠåžžçšã®æ äœãšçµã¿åãããŠæ¥è§Šæ§ç®è
çãçš®ã ã®æ¹¿ç¹ãç®èç¥çµçãçŽ ç®çãç«å·ãå€
é°åã³èéççãé ã錻ãç®èçŽ ææ§çŒç¡ã也
ç¬ãæå¹³åã³ç£ç¶çŽ è²èç¬ãåã³é¡äŒŒã®ç®èçŸæ£
ã®å±ææ²»çã«å¥œé©ã§ããã
ã®æ°èŠãããã³ãŒããŸã³èªå°äœã¯ã¬ãŒã¬ã³åŒè£œå€
ã«ãããŠåžžçšã®æ äœãšçµã¿åãããŠæ¥è§Šæ§ç®è
çãçš®ã ã®æ¹¿ç¹ãç®èç¥çµçãçŽ ç®çãç«å·ãå€
é°åã³èéççãé ã錻ãç®èçŽ ææ§çŒç¡ã也
ç¬ãæå¹³åã³ç£ç¶çŽ è²èç¬ãåã³é¡äŒŒã®ç®èçŸæ£
ã®å±ææ²»çã«å¥œé©ã§ããã
å»è¬èª¿å€ã®è£œé ã¯åžžæ³ã§ãããªãã¡äœçšç©è³ªã
奜é©ãªæ·»å ç©ãšå ±ã«ææã®é©çšå€åœ¢ãäŸãã°ïŒæº¶
æ¶²ãããŒã·ãšã³ãè»èãã¯ãªãŒã åã¯ç¡¬èãšãã
ããšã«ããè¡ãªãããããã®ããã«æåœ¢ãããè¬
å€ã«ãããŠãäœçšç©è³ªæ¿åºŠã¯é©çšå€åœ¢ã«ããæ±ºãŸ
ããããŒã·ãšã³åã³è»èã«ãããŠã¯äœçšç©è³ªæ¿åºŠ
0.001ïŒ ãïŒïŒ ãæå©ã«äœ¿çšããã
奜é©ãªæ·»å ç©ãšå ±ã«ææã®é©çšå€åœ¢ãäŸãã°ïŒæº¶
æ¶²ãããŒã·ãšã³ãè»èãã¯ãªãŒã åã¯ç¡¬èãšãã
ããšã«ããè¡ãªãããããã®ããã«æåœ¢ãããè¬
å€ã«ãããŠãäœçšç©è³ªæ¿åºŠã¯é©çšå€åœ¢ã«ããæ±ºãŸ
ããããŒã·ãšã³åã³è»èã«ãããŠã¯äœçšç©è³ªæ¿åºŠ
0.001ïŒ ãïŒïŒ ãæå©ã«äœ¿çšããã
æŽã«ãæ°èŠååç©ã¯å Žåã«ããåžžçšã®æ
äœåã³
å©å€ãšçµã¿åãããŠåžå ¥å€ã補é ããããã«ã奜
é©ã§ããããã®åžå ¥å€ã¯æ°ç®¡ã®ã¢ã¬ã«ã®ãŒæ§çŸ
æ£ãäŸãã°æ°ç®¡æ¯åæ¯åã¯éŒ»çã®æ²»çã«äœ¿çšãã
ããšãã§ããã
å©å€ãšçµã¿åãããŠåžå ¥å€ã補é ããããã«ã奜
é©ã§ããããã®åžå ¥å€ã¯æ°ç®¡ã®ã¢ã¬ã«ã®ãŒæ§çŸ
æ£ãäŸãã°æ°ç®¡æ¯åæ¯åã¯éŒ»çã®æ²»çã«äœ¿çšãã
ããšãã§ããã
æŽã«æ°èŠã³ã«ãã³ã€ããæå©ã«äœçšç©è³ª10ã
200mgã嫿ããã«ãã»ã«ãé å€åã¯ç³è¡£äžžã®åœ¢
ã§çµå£é©çšããããšã奜é©ã§ããããæå©ã«æäž
åäœãããäœçšç©è³ª100ã500mgã嫿ããæžæ¿æ¶²
ã®åœ¢ã§çŽè žæäžããããšã奜é©ã§ãããè žç®¡ã®ã¢
ã¬ã«ã®ãŒæ§çŸæ£ãäŸãã°æœ°çæ§çµè žçåã³èèœè «
æ§çµè žçã®æ²»çã®ããã«ã奜é©ã§ããã
200mgã嫿ããã«ãã»ã«ãé å€åã¯ç³è¡£äžžã®åœ¢
ã§çµå£é©çšããããšã奜é©ã§ããããæå©ã«æäž
åäœãããäœçšç©è³ª100ã500mgã嫿ããæžæ¿æ¶²
ã®åœ¢ã§çŽè žæäžããããšã奜é©ã§ãããè žç®¡ã®ã¢
ã¬ã«ã®ãŒæ§çŸæ£ãäŸãã°æœ°çæ§çµè žçåã³èèœè «
æ§çµè žçã®æ²»çã®ããã«ã奜é©ã§ããã
æ°èŠãããã³ãŒããŸã³èªå°äœã¯äžè¬åŒ
ãåŒäžãããR1åã³R2ã¯åèšã®ãã®ã衚ããã
ã®ãããã³ãŒããŸã³â21âã¢ã·ã¬ãŒããçžå¿ãã
17âã¢ã·ã¬ãŒãã«å€æããå Žåã«ãã21äœããšã¹
ãã«åããææã®å Žåã¯äžè¬åŒã®Î1,4âã¹ãã
ã€ãã«æ°ŽçŽ æ·»å ããÎ4âã¹ããã€ããšããããš
ã«ãã補é ããããšãã§ãããããã¯è¥¿ãã€ãåœ
ç¹èš±åºé¡ç¬¬2645104å·ãå第2645105å·åã³å第
2340591å·æçŽ°æžã«èšèŒãããŠããæ¡ä»¶äžã«å®æœ
ãããã
ã®ãããã³ãŒããŸã³â21âã¢ã·ã¬ãŒããçžå¿ãã
17âã¢ã·ã¬ãŒãã«å€æããå Žåã«ãã21äœããšã¹
ãã«åããææã®å Žåã¯äžè¬åŒã®Î1,4âã¹ãã
ã€ãã«æ°ŽçŽ æ·»å ããÎ4âã¹ããã€ããšããããš
ã«ãã補é ããããšãã§ãããããã¯è¥¿ãã€ãåœ
ç¹èš±åºé¡ç¬¬2645104å·ãå第2645105å·åã³å第
2340591å·æçŽ°æžã«èšèŒãããŠããæ¡ä»¶äžã«å®æœ
ãããã
次ã«ã宿œäŸã«ã€ãæ¬çºæã«ããæ¹æ³ã詳现ã«
説æããã
説æããã
äŸ ïŒ
(a) ããªãžã³150mlã®11βïŒ17ïŒ21âããªããã
ãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³15.0ïœ
ãïŒâã§ã¡ããã·é ¢é žã¯ããªãïŒmlãšå ±ã«ïŒæ
éæ¹æãããåŒãç¶ããæ°·æ°Žâå¡©åãããªãŠã
溶液äžã«æ³šããæ²æ®¿ç©ã濟å¥ããã·ãªã«ã²ã«
1.1Kgäžã§å¡©åã¡ãã¬ã³ïŒã¢ã»ãã³åŸææº¶æ¶²
ïŒïŒã20ïŒ ã¢ã»ãã³ïŒã§ç²Ÿè£œãããåéïŒ11βïŒ
17âãžããããã·â21âã¡ããã·ã¢ã»ããã·â
ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³15.2ïœãè
ç¹ïŒ232âã
ãã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³15.0ïœ
ãïŒâã§ã¡ããã·é ¢é žã¯ããªãïŒmlãšå ±ã«ïŒæ
éæ¹æãããåŒãç¶ããæ°·æ°Žâå¡©åãããªãŠã
溶液äžã«æ³šããæ²æ®¿ç©ã濟å¥ããã·ãªã«ã²ã«
1.1Kgäžã§å¡©åã¡ãã¬ã³ïŒã¢ã»ãã³åŸææº¶æ¶²
ïŒïŒã20ïŒ ã¢ã»ãã³ïŒã§ç²Ÿè£œãããåéïŒ11βïŒ
17âãžããããã·â21âã¡ããã·ã¢ã»ããã·â
ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³15.2ïœãè
ç¹ïŒ232âã
(b) ãšãŒãã«äžã®ã¡ãã«ãªããŠã ïŒïŒ
溶液ãã¢ã«
ãŽã³20mläžã«ïŒâã§ç¡æ°Žããã©ããããã©ã³64
mläžã®æ²åé ïŒïŒ3.2ïœã®æžæ¿æ¶²ã«æ»Žå ããã
ãã®é»è²æº¶æ¶²ãâ30âã«å·åŽããç¡æ°Žããã©ã
ãããã©ã³100mläžã®11βïŒ17âãžããããã·
â21âã¡ããã·ã¢ã»ããã·âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³2.9ïœã®æº¶æ¶²ãå ãããæŽã«ãâ
30âã§20åéæ¹æããå¡©åã¢ã³ã¢ããŠã 氎溶液
ã«å ãããå¡©åã¡ãã¬ã³ã§æœåºããåŸãææ©æº¶
æ¶²ãæŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿç¥ãããç
空äžã§æ¿çž®ãããç²çæç©ãã·ãªã«ã²ã«220ïœ
äžã§å¡©åã¡ãã¬ã³ïŒã¢ã»ãã³âåŸææº¶æ¶²ïŒïŒã
25ïŒ ã¢ã»ãã³ïŒã§ç²Ÿè£œããã11βïŒ21âãžãã
ããã·â17âã¡ããã·ã¢ã»ããã·âïŒâãã¬ã°
ãã³âïŒïŒ20âãžãªã³1.4ïœãåé¢ããããè
ç¹185â äŸ ïŒ (a) äŸ1aãšåæ§ã«ããŠããªãžã³100mläžã®11βïŒ
17ïŒ21âããªããããã·âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³10.0ïœããšããã·é ¢é žã¯ããªã
ïŒmlãšåå¿ãããåŠçãã粟補ãããåéïŒ21
âãšããã·ã¢ã»ããã·â11βïŒ17âãžãããã
ã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³10.3ïœã
èç¹ïŒ203âã
ãŽã³20mläžã«ïŒâã§ç¡æ°Žããã©ããããã©ã³64
mläžã®æ²åé ïŒïŒ3.2ïœã®æžæ¿æ¶²ã«æ»Žå ããã
ãã®é»è²æº¶æ¶²ãâ30âã«å·åŽããç¡æ°Žããã©ã
ãããã©ã³100mläžã®11βïŒ17âãžããããã·
â21âã¡ããã·ã¢ã»ããã·âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³2.9ïœã®æº¶æ¶²ãå ãããæŽã«ãâ
30âã§20åéæ¹æããå¡©åã¢ã³ã¢ããŠã 氎溶液
ã«å ãããå¡©åã¡ãã¬ã³ã§æœåºããåŸãææ©æº¶
æ¶²ãæŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿç¥ãããç
空äžã§æ¿çž®ãããç²çæç©ãã·ãªã«ã²ã«220ïœ
äžã§å¡©åã¡ãã¬ã³ïŒã¢ã»ãã³âåŸææº¶æ¶²ïŒïŒã
25ïŒ ã¢ã»ãã³ïŒã§ç²Ÿè£œããã11βïŒ21âãžãã
ããã·â17âã¡ããã·ã¢ã»ããã·âïŒâãã¬ã°
ãã³âïŒïŒ20âãžãªã³1.4ïœãåé¢ããããè
ç¹185â äŸ ïŒ (a) äŸ1aãšåæ§ã«ããŠããªãžã³100mläžã®11βïŒ
17ïŒ21âããªããããã·âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³10.0ïœããšããã·é ¢é žã¯ããªã
ïŒmlãšåå¿ãããåŠçãã粟補ãããåéïŒ21
âãšããã·ã¢ã»ããã·â11βïŒ17âãžãããã
ã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³10.3ïœã
èç¹ïŒ203âã
(b) äŸ1bã®æ¡ä»¶äžã«21âãšããã·ã¢ã»ããã·â
11βïŒ17âãžããããã·âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³10.0ïœããžã¡ãã«é é žãªããŠã
ïŒLithiumdimethylcupratïŒã§è»¢äœãããåŠç
ãããç²çæç©ãã·ãªã«ã²ã«700ïœäžã§ãããµ
ã³ïŒé ¢é žãšã¹ãã«âåŸææº¶æ¶²ïŒïŒã100ïŒ é ¢é ž
ãšã¹ãã«ïŒã§ç²Ÿè£œããã17âãšããã·ã¢ã»ãã
ã·â11βïŒ21âãžããããã·âïŒâãã¬ã°ãã³
âïŒïŒ20âãžãªã³4.1ïœãåŸããããèç¹161
âã
11βïŒ17âãžããããã·âïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³10.0ïœããžã¡ãã«é é žãªããŠã
ïŒLithiumdimethylcupratïŒã§è»¢äœãããåŠç
ãããç²çæç©ãã·ãªã«ã²ã«700ïœäžã§ãããµ
ã³ïŒé ¢é žãšã¹ãã«âåŸææº¶æ¶²ïŒïŒã100ïŒ é ¢é ž
ãšã¹ãã«ïŒã§ç²Ÿè£œããã17âãšããã·ã¢ã»ãã
ã·â11βïŒ21âãžããããã·âïŒâãã¬ã°ãã³
âïŒïŒ20âãžãªã³4.1ïœãåŸããããèç¹161
âã
äŸ ïŒ
(a) äŸ1aã«èšèŒããããã«ãããªãžã³200mläžã®
11βïŒ17ïŒ21âããªããããã·âïŒâãã¬ã°ã
ã³âïŒïŒ20âãžãªã³20.0ïœãïŒâã¡ããã·ãã
ããªã³é žã¯ããªããšåå¿ãããåŠçãã粟補ã
ããåçïŒ11βïŒ17âãžããããã·â21âïŒïŒ
âã¡ããã·ããããªãã«ãªãã·ïŒâïŒâãã¬ã°
ãã³âïŒïŒ20âãžãªã³12.8ïœãèç¹188âã
11βïŒ17ïŒ21âããªããããã·âïŒâãã¬ã°ã
ã³âïŒïŒ20âãžãªã³20.0ïœãïŒâã¡ããã·ãã
ããªã³é žã¯ããªããšåå¿ãããåŠçãã粟補ã
ããåçïŒ11βïŒ17âãžããããã·â21âïŒïŒ
âã¡ããã·ããããªãã«ãªãã·ïŒâïŒâãã¬ã°
ãã³âïŒïŒ20âãžãªã³12.8ïœãèç¹188âã
(b) äŸ1bãšåæ§ã«ããŠ11βïŒ17âãžããããã·â
21âïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâïŒâ
ãã¬ã°ãã³âïŒïŒ20âãžãªã³11.5ïœããžã¡ãã«
é é žãªããŠã ã§è»¢äœããåŠçãããã·ãªã«ã²ã«
750ïœäžã§å¡©åã¡ãã¬ã³ïŒã¢ã»ãã³âåŸææº¶æ¶²
ïŒïŒã30ïŒ ã¢ã»ãã³ïŒãçšããŠç²Ÿè£œãããš11βïŒ
21âãžããããã·â17âïŒïŒâã¡ããã·ããã
ãªãã«ãªãã·ïŒâïŒâãã¬ã°ãã³âïŒïŒ20âãž
ãªã³7.3ïœãåŸããããèç¹172âã
21âïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâïŒâ
ãã¬ã°ãã³âïŒïŒ20âãžãªã³11.5ïœããžã¡ãã«
é é žãªããŠã ã§è»¢äœããåŠçãããã·ãªã«ã²ã«
750ïœäžã§å¡©åã¡ãã¬ã³ïŒã¢ã»ãã³âåŸææº¶æ¶²
ïŒïŒã30ïŒ ã¢ã»ãã³ïŒãçšããŠç²Ÿè£œãããš11βïŒ
21âãžããããã·â17âïŒïŒâã¡ããã·ããã
ãªãã«ãªãã·ïŒâïŒâãã¬ã°ãã³âïŒïŒ20âãž
ãªã³7.3ïœãåŸããããèç¹172âã
äŸ ïŒ
(a) äŸ1aã®æ¡ä»¶äžã«11βïŒ17ïŒ21âããªãããã
ã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³10.0ïœã
ïŒâãšããã·ããããªã³é žã¯ããªããšåå¿ã
ããã·ãªã«ã²ã«1.5Kgäžã§ãããµã³ïŒé ¢é žãšã¹
ãã«âåŸææº¶æ¶²ïŒïŒã70ïŒ é ¢é žãšã¹ãã«ïŒãçš
ããŠã¯ãããã°ã©ãã€ãŒã«ããããåéïŒ21â
ïŒïŒâãšããã·ããããªãã«ãªãã·ïŒâ11βïŒ17
âãžããããã·âïŒâãã¬ã°ãã³âïŒïŒ20âãž
ãªã³9.7ïœãèç¹126âã
ã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³10.0ïœã
ïŒâãšããã·ããããªã³é žã¯ããªããšåå¿ã
ããã·ãªã«ã²ã«1.5Kgäžã§ãããµã³ïŒé ¢é žãšã¹
ãã«âåŸææº¶æ¶²ïŒïŒã70ïŒ é ¢é žãšã¹ãã«ïŒãçš
ããŠã¯ãããã°ã©ãã€ãŒã«ããããåéïŒ21â
ïŒïŒâãšããã·ããããªãã«ãªãã·ïŒâ11βïŒ17
âãžããããã·âïŒâãã¬ã°ãã³âïŒïŒ20âãž
ãªã³9.7ïœãèç¹126âã
(b) äŸ1bã«èšèŒããããã«21âïŒïŒâãšããã·ã
ãããªãã«ãªãã·ïŒâ11βïŒ17âãžããããã·
âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³9.0ïœããž
ã¡ãã«é é žãªããŠã ã§è»¢äœããåŠçããã¯ãã
ãã°ã©ãã€ãŒã«ãããã17âïŒïŒâãšããã·ã
ãããªãã«ãªãã·ïŒâ11βïŒ21âãžããããã·
âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ïŒïŒïŒïœã
åé¢ããããèç¹149âã
ãããªãã«ãªãã·ïŒâ11βïŒ17âãžããããã·
âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³9.0ïœããž
ã¡ãã«é é žãªããŠã ã§è»¢äœããåŠçããã¯ãã
ãã°ã©ãã€ãŒã«ãããã17âïŒïŒâãšããã·ã
ãããªãã«ãªãã·ïŒâ11βïŒ21âãžããããã·
âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ïŒïŒïŒïœã
åé¢ããããèç¹149âã
äŸ ïŒ
(a) ããªãžã³äžã®11βïŒ17ïŒ21âããªããããã·
âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³
10.0ïœã®æº¶æ¶²ãäŸ1aãšåæ§ã«ããŠã¡ããã·é ¢é ž
ã¯ããªããšåå¿ãããåŠçãã粟補ããã
11βïŒ17âãžããããã·â21âã¡ããã·ã¢ã»ã
ãã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãª
ã³10.3ïœãåé¢ãããã
âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³
10.0ïœã®æº¶æ¶²ãäŸ1aãšåæ§ã«ããŠã¡ããã·é ¢é ž
ã¯ããªããšåå¿ãããåŠçãã粟補ããã
11βïŒ17âãžããããã·â21âã¡ããã·ã¢ã»ã
ãã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãª
ã³10.3ïœãåé¢ãããã
(b) 11βïŒ17âãžããããã·â21âã¡ããã·ã¢ã»
ããã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãž
ãªã³9.0ïœãäŸ1bãšåæ§ã«ããŠãžã¡ãã«é é žãª
ããŠã ãçšããŠè»¢äœãããåŠçãã粟補ããã
11βïŒ21âãžããããã·â17âã¡ããã·ã¢ã»ã
ãã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãª
ã³3.6ïœãåŸãããã
ããã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãž
ãªã³9.0ïœãäŸ1bãšåæ§ã«ããŠãžã¡ãã«é é žãª
ããŠã ãçšããŠè»¢äœãããåŠçãã粟補ããã
11βïŒ21âãžããããã·â17âã¡ããã·ã¢ã»ã
ãã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãª
ã³3.6ïœãåŸãããã
(c) 11βïŒ21âãžããããã·â17âã¡ããã·ã¢ã»
ããã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãž
ãªã³1.5ïœãããªãžã³15mlåã³ç¡æ°Žé ¢é ž7.5mläž
ã§ïŒæéå®€æž©ã§æ¹æãããåŒãç¶ããæ°·æ°Žâå¡©
åãããªãŠã 溶液äžã«æ³šããæ²æ®¿ãæ¿Ÿå¥ããç²
çæç©ãã·ãªã«ã²ã«100ïœäžã§å¡©åã¡ãã¬ã³ïŒ
ã¢ã»ãã³âåŸææº¶æ¶²ïŒïŒã20ïŒ ã¢ã»ãã³ïŒãçš
ããŠç²Ÿè£œãããåéïŒ21âã¢ã»ããã·â11βâ
ããããã·â17âã¡ããã·ã¢ã»ããã·âïŒïŒïŒ
âãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³1.2ïœã
ããã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãž
ãªã³1.5ïœãããªãžã³15mlåã³ç¡æ°Žé ¢é ž7.5mläž
ã§ïŒæéå®€æž©ã§æ¹æãããåŒãç¶ããæ°·æ°Žâå¡©
åãããªãŠã 溶液äžã«æ³šããæ²æ®¿ãæ¿Ÿå¥ããç²
çæç©ãã·ãªã«ã²ã«100ïœäžã§å¡©åã¡ãã¬ã³ïŒ
ã¢ã»ãã³âåŸææº¶æ¶²ïŒïŒã20ïŒ ã¢ã»ãã³ïŒãçš
ããŠç²Ÿè£œãããåéïŒ21âã¢ã»ããã·â11βâ
ããããã·â17âã¡ããã·ã¢ã»ããã·âïŒïŒïŒ
âãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³1.2ïœã
äŸ ïŒ
(a) 11βïŒ17ïŒ21âããªããããã·âïŒïŒïŒâã
ã¬ã°ããžãšã³âïŒïŒ20âãžãªã³10.0ïœãäŸ2aãš
åæ§ã«ããŠãšããã·é ¢é žã¯ããªããšåå¿ããã
åŠçãã粟補ããã21âãšããã·ã¢ã»ããã·â
11βïŒ17âãžããããã·âïŒïŒïŒâãã¬ã°ããž
ãšã³âïŒïŒ20âãžãªã³10.4ïœãåé¢ããã
ã¬ã°ããžãšã³âïŒïŒ20âãžãªã³10.0ïœãäŸ2aãš
åæ§ã«ããŠãšããã·é ¢é žã¯ããªããšåå¿ããã
åŠçãã粟補ããã21âãšããã·ã¢ã»ããã·â
11βïŒ17âãžããããã·âïŒïŒïŒâãã¬ã°ããž
ãšã³âïŒïŒ20âãžãªã³10.4ïœãåé¢ããã
(b) äŸ2bãšåæ§ã«ããŠã21âãšããã·ã¢ã»ãã
ã·â11βïŒ17âãžããããã·âïŒïŒïŒâãã¬ã°
ããžãšã³âïŒïŒ20âãžãªã³6.0ïœããžã¡ãã«é
é žãªããŠã ã§è»¢äœããåŠçãã粟補ãããå
éïŒ17âãšããã·ã¢ã»ããã·â11βïŒ21âãžã
ãããã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20â
ãžãªã³2.5ïœã
ã·â11βïŒ17âãžããããã·âïŒïŒïŒâãã¬ã°
ããžãšã³âïŒïŒ20âãžãªã³6.0ïœããžã¡ãã«é
é žãªããŠã ã§è»¢äœããåŠçãã粟補ãããå
éïŒ17âãšããã·ã¢ã»ããã·â11βïŒ21âãžã
ãããã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20â
ãžãªã³2.5ïœã
äŸ ïŒ
(a) äŸ3aã®æ¡ä»¶äžã«11βïŒ17ïŒ21âããªãããã
ã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³
10.0ïœãšïŒâã¡ããã·ããããªã³é žã¯ããªããš
ãåå¿ãããåŠçãã粟補ããã11βïŒ17âãž
ããããã·â21âïŒïŒâã¡ããã·ããããªãã«
ãªãã·ïŒâïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20â
ãžãªã³7.3ïœãåé¢ãããã
ã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³
10.0ïœãšïŒâã¡ããã·ããããªã³é žã¯ããªããš
ãåå¿ãããåŠçãã粟補ããã11βïŒ17âãž
ããããã·â21âïŒïŒâã¡ããã·ããããªãã«
ãªãã·ïŒâïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20â
ãžãªã³7.3ïœãåé¢ãããã
(b) äŸ1bãšåæ§ã«ããŠ11βïŒ17âãžããããã·â
21âïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâïŒïŒ
ïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³7.0ïœã
ãªããŠã ãžã¡ãã«ã¯ãã¬ãŒãã§è»¢äœãããåŠç
ãã粟補ãããåéïŒ11βïŒ21âãžããããã·
â17âïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâ
ïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³3.9
ïœã
21âïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâïŒïŒ
ïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³7.0ïœã
ãªããŠã ãžã¡ãã«ã¯ãã¬ãŒãã§è»¢äœãããåŠç
ãã粟補ãããåéïŒ11βïŒ21âãžããããã·
â17âïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâ
ïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³3.9
ïœã
(c) äŸ5cã«èšèŒãããŠãããšåæ§ã«ããŠã11βïŒ
21âãžããããã·â17âïŒïŒâã¡ããã·ããã
ãªãã«ãªãã·ïŒâïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ
20âãžãªã³1.0ïœãšç¡æ°Žé ¢é žãšã宀枩ã§åå¿ã
ããåŠçãã粟補ããã21âã¢ã»ããã·â11β
âããããã·â17âïŒïŒâã¡ããã·ããããªã
ã«ãªãã·ïŒâïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20
âãžãªã³810mgãåé¢ãããã
21âãžããããã·â17âïŒïŒâã¡ããã·ããã
ãªãã«ãªãã·ïŒâïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ
20âãžãªã³1.0ïœãšç¡æ°Žé ¢é žãšã宀枩ã§åå¿ã
ããåŠçãã粟補ããã21âã¢ã»ããã·â11β
âããããã·â17âïŒïŒâã¡ããã·ããããªã
ã«ãªãã·ïŒâïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20
âãžãªã³810mgãåé¢ãããã
äŸ ïŒ
(a) 11βïŒ17ïŒ21âããªããããã·â6αâã¡ãã«
âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³
15.0ïœãäŸ1aãšåæ§ã«ããŠã¡ããã·é ¢é žã¯ããª
ããšåå¿ãããåŠçãã粟補ãããåéïŒ
11βïŒ17âãžããããã·â21âã¡ããã·ã¢ã»ã
ãã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³
âïŒïŒ20âãžãªã³15.4ïœãèç¹219âã
âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³
15.0ïœãäŸ1aãšåæ§ã«ããŠã¡ããã·é ¢é žã¯ããª
ããšåå¿ãããåŠçãã粟補ãããåéïŒ
11βïŒ17âãžããããã·â21âã¡ããã·ã¢ã»ã
ãã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³
âïŒïŒ20âãžãªã³15.4ïœãèç¹219âã
(b) äŸ1bã®æ¡ä»¶äžã«11βïŒ17âãžããããã·â21
âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒ
âãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³15.0ïœããž
ã¡ãã«é é žãªããŠã ã§è»¢äœããåŠçãããç²ç
æç©ãã·ãªã«ã²ã«400ïœäžãããµã³ïŒã¢ã»ãã³
âåŸææº¶æ¶²ïŒïŒã50ïŒ ã¢ã»ãã³ïŒã§ç²Ÿè£œããã
åéïŒ11βïŒ21âãžããããã·â17âã¡ããã·
ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ã
ãžãšã³âïŒïŒ20âãžãªã³9.3ïœãèç¹202âã
âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒ
âãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³15.0ïœããž
ã¡ãã«é é žãªããŠã ã§è»¢äœããåŠçãããç²ç
æç©ãã·ãªã«ã²ã«400ïœäžãããµã³ïŒã¢ã»ãã³
âåŸææº¶æ¶²ïŒïŒã50ïŒ ã¢ã»ãã³ïŒã§ç²Ÿè£œããã
åéïŒ11βïŒ21âãžããããã·â17âã¡ããã·
ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ã
ãžãšã³âïŒïŒ20âãžãªã³9.3ïœãèç¹202âã
äŸ ïŒ
11βïŒ21âãžããããã·â17âã¡ããã·ã¢ã»ã
ãã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³â
ïŒïŒ20âãžãªã³2.0ïœãäŸ5cã®æ¡ä»¶äžã«ç¡æ°Žé ¢é ž
ãšåå¿ãããåŠçãã粟補ãããåéïŒ21âã¢ã»
ããã·â11βâããããã·â17âã¡ããã·ã¢ã»ã
ãã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³â
ïŒïŒ20âãžãªã³ãèç¹151âã
ãã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³â
ïŒïŒ20âãžãªã³2.0ïœãäŸ5cã®æ¡ä»¶äžã«ç¡æ°Žé ¢é ž
ãšåå¿ãããåŠçãã粟補ãããåéïŒ21âã¢ã»
ããã·â11βâããããã·â17âã¡ããã·ã¢ã»ã
ãã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³â
ïŒïŒ20âãžãªã³ãèç¹151âã
äŸ 10
(a) äŸ2aã«èšèŒãããšåæ§ã«ããŠã11βïŒ17ïŒ21
âããªããããã·â6αâã¡ãã«âïŒïŒïŒâã
ã¬ã°ããžãšã³âïŒïŒ20âãžãªã³15.0ïœããšãã
ã·é ¢é žã¯ããªããšåå¿ãããåŠçãã粟補ã
ãã21âãšããã·ã¢ã»ããã·â11βïŒ17âãžã
ãããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããž
ãšã³âïŒïŒ20âãžãªã³15.6ïœãåé¢ãããèç¹
229âã
âããªããããã·â6αâã¡ãã«âïŒïŒïŒâã
ã¬ã°ããžãšã³âïŒïŒ20âãžãªã³15.0ïœããšãã
ã·é ¢é žã¯ããªããšåå¿ãããåŠçãã粟補ã
ãã21âãšããã·ã¢ã»ããã·â11βïŒ17âãžã
ãããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããž
ãšã³âïŒïŒ20âãžãªã³15.6ïœãåé¢ãããèç¹
229âã
(b) 21âãšããã·ã¢ã»ããã·â11βïŒ17âãžãã
ããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãš
ã³âïŒïŒ20âãžãªã³15.0ïœãäŸ2bã®æ¡ä»¶äžã«ãž
ã¡ãã«é é žãªããŠã ã§è»¢äœãåŠçãã粟補ã
ããåéïŒ17âãšããã·ã¢ã»ããã·â11βïŒ21
âãžããããã·â6αâã¡ãã«âïŒïŒïŒâãã¬
ã°ããžãšã³âïŒïŒ20âãžãªã³8.3ïœãèç¹198
âã
ããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãš
ã³âïŒïŒ20âãžãªã³15.0ïœãäŸ2bã®æ¡ä»¶äžã«ãž
ã¡ãã«é é žãªããŠã ã§è»¢äœãåŠçãã粟補ã
ããåéïŒ17âãšããã·ã¢ã»ããã·â11βïŒ21
âãžããããã·â6αâã¡ãã«âïŒïŒïŒâãã¬
ã°ããžãšã³âïŒïŒ20âãžãªã³8.3ïœãèç¹198
âã
äŸ 11
17âãšããã·ã¢ã»ããã·â11βïŒ21âãžããã
ãã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³â
ïŒïŒ20âãžãªã³2.0ïœãäŸ5cãšåæ§ã«ããŠç¡æ°Žé ¢
é žãšåå¿ãããåŠçãã粟補ãããåéïŒ21âã¢
ã»ããã·â17âãšããã·ã¢ã»ããã·â11βâãã
ããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³
âïŒïŒ20âãžãªã³1.9ïœãèç¹170âã
ãã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³â
ïŒïŒ20âãžãªã³2.0ïœãäŸ5cãšåæ§ã«ããŠç¡æ°Žé ¢
é žãšåå¿ãããåŠçãã粟補ãããåéïŒ21âã¢
ã»ããã·â17âãšããã·ã¢ã»ããã·â11βâãã
ããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³
âïŒïŒ20âãžãªã³1.9ïœãèç¹170âã
äŸ 12
(a) äŸ3aã®æ¡ä»¶äžã«11βïŒ17ïŒ21âããªãããã
ã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³â
ïŒïŒ20âãžãªã³15.0ïœãïŒâã¡ããã·ããããª
ã³é žã¯ããªããšåå¿ãããåŠçãã粟補ããã
11βïŒ17âãžããããã·â21âïŒïŒâã¡ããã·
ããããªãã«ãªãã·ïŒâïŒïŒïŒâãã¬ã°ããžãš
ã³âïŒïŒ20âãžãªã³14.3ïœãåé¢ãããèç¹
230âã
ã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³â
ïŒïŒ20âãžãªã³15.0ïœãïŒâã¡ããã·ããããª
ã³é žã¯ããªããšåå¿ãããåŠçãã粟補ããã
11βïŒ17âãžããããã·â21âïŒïŒâã¡ããã·
ããããªãã«ãªãã·ïŒâïŒïŒïŒâãã¬ã°ããžãš
ã³âïŒïŒ20âãžãªã³14.3ïœãåé¢ãããèç¹
230âã
(b) 11βïŒ17âãžããããã·â21âïŒïŒâã¡ãã
ã·ããããªãã«ãªãã·ïŒâïŒïŒïŒâãã¬ã°ããž
ãšã³âïŒïŒ20âãžãªã³8.8ïœãäŸ3bãšåæ§ã«ã
ãŠãžã¡ãã«é é žãªããŠã ã§è»¢äœããåŠçãã粟
補ãããåéïŒ11βïŒ21âãžããããã·â17â
ïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâ6αâã¡
ãã«âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãª
ã³3.2ïœãèç¹ïŒ151âã
ã·ããããªãã«ãªãã·ïŒâïŒïŒïŒâãã¬ã°ããž
ãšã³âïŒïŒ20âãžãªã³8.8ïœãäŸ3bãšåæ§ã«ã
ãŠãžã¡ãã«é é žãªããŠã ã§è»¢äœããåŠçãã粟
補ãããåéïŒ11βïŒ21âãžããããã·â17â
ïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâ6αâã¡
ãã«âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãª
ã³3.2ïœãèç¹ïŒ151âã
äŸ 13
11βïŒ21âãžããããã·â17âïŒïŒâã¡ããã·
ããããªãã«ãªãã·ïŒâ6αâã¡ãã«âïŒïŒïŒâã
ã¬ã°ããžãšã³âïŒïŒ20âãžãªã³2.0ïœãäŸ5cãšå
æ§ã«ããŠç¡æ°Žé ¢é žãšåå¿ãããåŠçãã粟補ã
ãã21âã¢ã»ããã·â11βâããããã·â17â
ïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâ6αâã¡ã
ã«âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³
13.6ïœãåé¢ããããèç¹ïŒ162âã
ããããªãã«ãªãã·ïŒâ6αâã¡ãã«âïŒïŒïŒâã
ã¬ã°ããžãšã³âïŒïŒ20âãžãªã³2.0ïœãäŸ5cãšå
æ§ã«ããŠç¡æ°Žé ¢é žãšåå¿ãããåŠçãã粟補ã
ãã21âã¢ã»ããã·â11βâããããã·â17â
ïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâ6αâã¡ã
ã«âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³
13.6ïœãåé¢ããããèç¹ïŒ162âã
äŸ 14
(a) äŸ4aãšåæ§ã«ããŠã11βïŒ17ïŒ21âããªãã
ããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãš
ã³âïŒïŒ20âãžãªã³15.0ïœãšïŒâãšããã·ãã
ããªã³é žã¯ããªããšãåå¿ãããåŠçãã粟補
ããã21âïŒïŒâãšããã·ããããªãã«ãªãã·ïŒ
â11βïŒ17âãžããããã·â6αâã¡ãã«âïŒïŒ
ïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³13.6ïœã
åé¢ããããèç¹ïŒ186âã
ããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãš
ã³âïŒïŒ20âãžãªã³15.0ïœãšïŒâãšããã·ãã
ããªã³é žã¯ããªããšãåå¿ãããåŠçãã粟補
ããã21âïŒïŒâãšããã·ããããªãã«ãªãã·ïŒ
â11βïŒ17âãžããããã·â6αâã¡ãã«âïŒïŒ
ïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³13.6ïœã
åé¢ããããèç¹ïŒ186âã
(b) 21âïŒïŒâãšããã·ããããªãã«ãªãã·ïŒâ
11βïŒ17âãžããããã·â6αâã¡ãã«âïŒïŒïŒ
âãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³10.0ïœã®ãž
ã¡ãã«é é žãªããŠã ãçšããŠã®è»¢äœãäŸ4bãš
åæ§ã«å®æœãããåŠçåã³ç²Ÿè£œã®åŸã17âïŒïŒ
âãšããã·ããããªãã«ãªãã·ïŒâ11βïŒ21â
ãžããããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°
ããžãšã³âïŒïŒ20âãžãªã³4.1ïœãåŸãããã
èç¹167âã
11βïŒ17âãžããããã·â6αâã¡ãã«âïŒïŒïŒ
âãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³10.0ïœã®ãž
ã¡ãã«é é žãªããŠã ãçšããŠã®è»¢äœãäŸ4bãš
åæ§ã«å®æœãããåŠçåã³ç²Ÿè£œã®åŸã17âïŒïŒ
âãšããã·ããããªãã«ãªãã·ïŒâ11βïŒ21â
ãžããããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°
ããžãšã³âïŒïŒ20âãžãªã³4.1ïœãåŸãããã
èç¹167âã
äŸ 15
äŸ5cã«èšèŒãããŠãããšåæ§ã«ããŠ17âïŒïŒâ
ãšããã·ããããªãã«ãªãã·ïŒâ11βïŒ21âãžã
ãããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãš
ã³âïŒïŒ20âãžãªã³2.0ïœãšç¡æ°Žé ¢é žãšãåå¿ã
ããåŠçãã粟補ãããåéïŒ21âã¢ã»ããã·â
17âïŒïŒâãšããã·ããããªãã«ãªãã·ïŒâ11βâ
ããããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããž
ãšã³âïŒïŒ20âãžãªã³1.34ïœãèç¹131âã
ãšããã·ããããªãã«ãªãã·ïŒâ11βïŒ21âãžã
ãããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãš
ã³âïŒïŒ20âãžãªã³2.0ïœãšç¡æ°Žé ¢é žãšãåå¿ã
ããåŠçãã粟補ãããåéïŒ21âã¢ã»ããã·â
17âïŒïŒâãšããã·ããããªãã«ãªãã·ïŒâ11βâ
ããããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããž
ãšã³âïŒïŒ20âãžãªã³1.34ïœãèç¹131âã
äŸ 16
äŸ5cãšåæ§ã«ããŠã11βïŒ21âãžããããã·â
17âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒ
âãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³1.0ïœãšãã
ããªã³é žç¡æ°Žç©ãšã宀枩ã§åå¿ãããåŠçãã粟
補ããã11βâããããã·â17âã¡ããã·ã¢ã»ã
ãã·â21âããããªãã«ãªãã·â6αâã¡ãã«â
ïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³780mg
ãåé¢ãããã
17âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒ
âãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³1.0ïœãšãã
ããªã³é žç¡æ°Žç©ãšã宀枩ã§åå¿ãããåŠçãã粟
補ããã11βâããããã·â17âã¡ããã·ã¢ã»ã
ãã·â21âããããªãã«ãªãã·â6αâã¡ãã«â
ïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³780mg
ãåé¢ãããã
äŸ 17
äŸ5cã®æ¡ä»¶äžã«11βïŒ21âãžããããã·â17â
ã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒâã
ã¬ã°ããžãšã³âïŒïŒ20âãžãªã³1.2ïœãé ªé žç¡æ°Ž
ç©ãšå ±ã«å®€æž©ã§åå¿ãããåŠçãã粟補ããã21
âãããªã«ãªãã·â11βâããããã·â17âã¡ã
ãã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°
ããžãšã³âïŒïŒ20âãžãªã³730mgãåŸãããã
ã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒâã
ã¬ã°ããžãšã³âïŒïŒ20âãžãªã³1.2ïœãé ªé žç¡æ°Ž
ç©ãšå ±ã«å®€æž©ã§åå¿ãããåŠçãã粟補ããã21
âãããªã«ãªãã·â11βâããããã·â17âã¡ã
ãã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°
ããžãšã³âïŒïŒ20âãžãªã³730mgãåŸãããã
äŸ 18
äŸ5cã®æ¡ä»¶äžã«11βïŒ21âãžããããã·â17â
ã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒâã
ã¬ã°ããžãšã³âïŒïŒ20âãžãªã³1.0ïœãã€ãœé ªé ž
ç¡æ°Žç©ãšåå¿ãããåŠçãã粟補ãããåéïŒ
11βâããããã·â21âã€ãœãããªã«ãªãã·â17
âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒâ
ãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³590mgã
ã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒâã
ã¬ã°ããžãšã³âïŒïŒ20âãžãªã³1.0ïœãã€ãœé ªé ž
ç¡æ°Žç©ãšåå¿ãããåŠçãã粟補ãããåéïŒ
11βâããããã·â21âã€ãœãããªã«ãªãã·â17
âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒâ
ãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³590mgã
äŸ 19
11βïŒ21âãžããããã·â17âã¡ããã·ã¢ã»ã
ãã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³â
ïŒïŒ20âãžãªã³3.0ïœããã³ãŸãŒã«225mlåã³ã¡ã¿
ããŒã«75mlãããªãæ··åç©äžã§ããªã¹ïŒããªããš
ãã«ãã¹ãã€ã³ïŒããžãŠã ââã¯ããªã2.7ïœ
ãçšããŠ6.5æéå®€æž©ã§æ°ŽçŽ æ·»å ãããç空äžã§
èžçºä¹Ÿæ¶žããç²çæç©ãã·ãªã«ã²ã«350ïœäžã§ã
ããµã³ïŒã¢ã»ãã³âåŸææº¶æ¶²ïŒïŒã50ïŒ ã¢ã»ã
ã³ïŒã§ç²Ÿè£œãããåéïŒ11βïŒ21âãžããããã·
â17âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒâ
ãã¬ã°ãã³âïŒïŒ20âãžãªã³2.5ïœã
ãã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³â
ïŒïŒ20âãžãªã³3.0ïœããã³ãŸãŒã«225mlåã³ã¡ã¿
ããŒã«75mlãããªãæ··åç©äžã§ããªã¹ïŒããªããš
ãã«ãã¹ãã€ã³ïŒããžãŠã ââã¯ããªã2.7ïœ
ãçšããŠ6.5æéå®€æž©ã§æ°ŽçŽ æ·»å ãããç空äžã§
èžçºä¹Ÿæ¶žããç²çæç©ãã·ãªã«ã²ã«350ïœäžã§ã
ããµã³ïŒã¢ã»ãã³âåŸææº¶æ¶²ïŒïŒã50ïŒ ã¢ã»ã
ã³ïŒã§ç²Ÿè£œãããåéïŒ11βïŒ21âãžããããã·
â17âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒâ
ãã¬ã°ãã³âïŒïŒ20âãžãªã³2.5ïœã
äŸ 20
äŸ19ãšåæ§ã«ããŠã21âã¢ã»ããã·â11βâã
ãããã·â17âã¡ããã·ã¢ã»ããã·â6αâã¡ã
ã«âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³
1.5ïœãããªã¹ïŒããªããšãã«ãã¹ãã€ã³ïŒããž
ãŠã ââã¯ããªã1.2ïœãçšããŠæ°ŽçŽ æ·»å ãã
åŠçãã粟補ãããåéïŒ21âã¢ã»ããã·â11β
âããããã·â17âã¡ããã·ã¢ã»ããã·â6αâ
ã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³1.1ïœ äŸ 21 äŸ19ã«ããããšåæ§ã«ã17âãšããã·ã¢ã»ãã
ã·â11βïŒ21âãžããããã·â6αâã¡ãã«âïŒïŒ
ïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³1.0ïœãã
ãªã¹ïŒããªããšãã«ãã¹ãã€ã³ïŒããžãŠã ââ
ã¯ããªã700mgã§æ°ŽçŽ æ·»å ãããåŠçåã³ç²Ÿè£œã®
åŸã17âãšããã·ã¢ã»ããã·â11βïŒ21âãžãã
ããã·â6αâã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³790mgãåé¢ãããã
ãããã·â17âã¡ããã·ã¢ã»ããã·â6αâã¡ã
ã«âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³
1.5ïœãããªã¹ïŒããªããšãã«ãã¹ãã€ã³ïŒããž
ãŠã ââã¯ããªã1.2ïœãçšããŠæ°ŽçŽ æ·»å ãã
åŠçãã粟補ãããåéïŒ21âã¢ã»ããã·â11β
âããããã·â17âã¡ããã·ã¢ã»ããã·â6αâ
ã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³1.1ïœ äŸ 21 äŸ19ã«ããããšåæ§ã«ã17âãšããã·ã¢ã»ãã
ã·â11βïŒ21âãžããããã·â6αâã¡ãã«âïŒïŒ
ïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³1.0ïœãã
ãªã¹ïŒããªããšãã«ãã¹ãã€ã³ïŒããžãŠã ââ
ã¯ããªã700mgã§æ°ŽçŽ æ·»å ãããåŠçåã³ç²Ÿè£œã®
åŸã17âãšããã·ã¢ã»ããã·â11βïŒ21âãžãã
ããã·â6αâã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³790mgãåé¢ãããã
äŸ 22
äŸ19ã®æ¡ä»¶äžã«21âã¢ã»ããã·â11βâããã
ãã·â17âïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâ
6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20
âãžãªã³1.5ïœãããªã¹ïŒããªããšãã«ãã¹ãã€
ã³ïŒããžãŠã ââã¯ããªã1.2ïœã§æ°ŽçŽ æ·»å ãã
åŠçãã粟補ãããåéïŒ21âã¢ã»ããã·â11β
âããããã·â17âïŒïŒâã¡ããã·ããããªãã«
ãªãã·ïŒâ6αâã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³1.2ïœã
ãã·â17âïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâ
6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20
âãžãªã³1.5ïœãããªã¹ïŒããªããšãã«ãã¹ãã€
ã³ïŒããžãŠã ââã¯ããªã1.2ïœã§æ°ŽçŽ æ·»å ãã
åŠçãã粟補ãããåéïŒ21âã¢ã»ããã·â11β
âããããã·â17âïŒïŒâã¡ããã·ããããªãã«
ãªãã·ïŒâ6αâã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³1.2ïœã
äŸ 23
(a) äŸ1aãšåæ§ã«ããŠ11βïŒ17ïŒ21âããªããã
ãã·â6αâã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³1.5ïœãäŸ1aãšåæ§ã«ããŠã¡ããã·é ¢
é žã¯ããªããšåå¿ãããåŠçããã¯ãããã°ã©
ãã€ãŒã«ãããã11βïŒ17âãžããããã·â21
âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒâã
ã¬ã°ãã³âïŒïŒ20âãžãªã³1.6ïœãåé¢ãããã
ãã·â6αâã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³1.5ïœãäŸ1aãšåæ§ã«ããŠã¡ããã·é ¢
é žã¯ããªããšåå¿ãããåŠçããã¯ãããã°ã©
ãã€ãŒã«ãããã11βïŒ17âãžããããã·â21
âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒâã
ã¬ã°ãã³âïŒïŒ20âãžãªã³1.6ïœãåé¢ãããã
(b) äŸ1bã®æ¡ä»¶äžã«11βïŒ17âãžããããã·â21
âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒâã
ã¬ã°ãã³âïŒïŒ20âãžãªã³1.5ïœããžã¡ãã«é
é žãªããŠã ã§è»¢äœãããåŠçãã粟補ãããå
éïŒ11βïŒ21âãžããããã·â17âã¡ããã·ã¢
ã»ããã·â6αâã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ
20âãžãªã³690mgã
âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒâã
ã¬ã°ãã³âïŒïŒ20âãžãªã³1.5ïœããžã¡ãã«é
é žãªããŠã ã§è»¢äœãããåŠçãã粟補ãããå
éïŒ11βïŒ21âãžããããã·â17âã¡ããã·ã¢
ã»ããã·â6αâã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ
20âãžãªã³690mgã
äŸ 24
äŸ5cã«èšèŒãããŠããããã«ã11βïŒ21âãžã
ãããã·â17âã¡ããã·ã¢ã»ããã·â6αâã¡ã
ã«âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³600mgãç¡
æ°Žé ¢é žãšåå¿ãããåŠçããã¯ãããã°ã©ãã€ãŒ
ã«ãããã21âã¢ã»ããã·â11βâããããã·â
17âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒâã
ã¬ã°ãã³âïŒïŒ20âãžãªã³480mgãåé¢ãããã
ãããã·â17âã¡ããã·ã¢ã»ããã·â6αâã¡ã
ã«âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³600mgãç¡
æ°Žé ¢é žãšåå¿ãããåŠçããã¯ãããã°ã©ãã€ãŒ
ã«ãããã21âã¢ã»ããã·â11βâããããã·â
17âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒâã
ã¬ã°ãã³âïŒïŒ20âãžãªã³480mgãåé¢ãããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒïŒ åŒäžããã¯åçµååã¯äºéçµåã衚ãããïœã¯
æ°ïŒåã¯ïŒã衚ãããR1ã¯æ°ŽçŽ åååã¯ã¡ãã«
åºã衚ãããR2ã¯ççŽ ååæ°ïŒãïŒã®ã¢ã«ãã«
åºã衚ãããR3ã¯æ°ŽçŽ åååã¯ççŽ ååæ°ïŒã
ïŒã®ïŒâãªããœã¢ã«ãã«åºã衚ããã®ãããã³
ãŒããŸã³èªå°äœã ïŒ 17âãšããã·ã¢ã»ããã·â11βïŒ21âãžãã
ããã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ 11βïŒ21âãžããããã·â17âã¡ããã·ã¢ã»
ããã·âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ 17âïŒïŒâãšããã·ããããªãã«ãªãã·ïŒâ
11βïŒ21âãžããããã·â6αâã¡ãã«âïŒâãã¬
ã°ãã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®ååç©ã ïŒ 11βïŒ21âãžããããã·â17âïŒïŒâã¡ãã
ã·ããããªãã«ãªãã·ïŒâïŒâãã¬ã°ãã³âïŒïŒ
20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å
åç©ã ïŒ 17âãšããã·ã¢ã»ããã·â11βïŒ21âãžãã
ããã·âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãª
ã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ 21âã¢ã»ããã·â11βâããããã·â17â
ïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâïŒïŒïŒâã
ã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ 11βïŒ21âãžããããã·â17âïŒïŒâã¡ãã
ã·ããããªãã«ãªãã·ïŒâ6αâã¡ãã«âïŒïŒïŒâ
ãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ 21âã¢ã»ããã·â11βâããããã·â17â
ïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâ6αâã¡ã
ã«âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ã§
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ 21âã¢ã»ããã·â11βâããããã·â17â
ã¡ããã·ã¢ã»ããã·âïŒïŒïŒâãã¬ã°ããžãšã³â
ïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®ååç©ã ïŒïŒ 17âãšããã·ã¢ã»ããã·â11βïŒ21âãžã
ãããã·â6αâã¡ãã«âïŒïŒïŒâãã¬ã°ããžãš
ã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
èšèŒã®ååç©ã ïŒïŒ 17âïŒïŒâãšããã·ãããããªãã«ãªãã·ïŒ
â11βïŒ21âãžããããã·â6αâã¡ãã«âïŒïŒïŒ
âãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ 21âã¢ã»ããã·â17âïŒïŒâãšããã·ãã
ãããªãã«ãªãã·ïŒâ11βâããããã·â6αâã¡
ãã«âïŒïŒïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³
ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ 11βâããããã·â17âã¡ããã·ã¢ã»ãã
ã·â6αâã¡ãã«â21âããããªãã«ãªãã·âïŒïŒ
ïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ 21âãããªã«ãªãã·â11βâããããã·â
17âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒïŒ
âãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ 21âã¢ã»ããã·â11βâããããã·â17â
ã¡ããã·ã¡ããã·â6αâã¡ãã«âïŒïŒïŒâãã¬
ã°ããžãšã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ 11βâããããã·â21âã€ãœãããªã«ãªã
ã·â17âã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒïŒ
ïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ 21âã¢ã»ããã·â17âãšããã·ã¢ã»ããã·
â11βâããããã·â6αâã¡ãã«âïŒïŒïŒâãã¬
ã°ããžãšã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ 11βïŒ21âãžããããã·â17âã¡ããã·ã¢
ã»ããã·â6αâã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ
20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å
åç©ã ïŒïŒ 17âãšããã·ã¢ã»ããã·â11βïŒ21âãžã
ãããã·â6αâã¡ãã«âïŒâãã¬ã°ãã³âïŒïŒ
20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å
åç©ã ïŒïŒ 21âã¢ã»ããã·â11βâããããã·â17â
ã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒâãã¬ã°
ãã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é èšèŒã®ååç©ã ïŒïŒ 21âã¢ã»ããã·â11βâããããã·â17â
ïŒïŒâã¡ããã·ããããªãã«ãªãã·ïŒâ6αâã¡ã
ã«âïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ 21âã¢ã»ããã·â11βâããããã·â17â
ã¡ããã·ã¢ã»ããã·â6αâã¡ãã«âïŒâãã¬ã°
ãã³âïŒïŒ20âãžãªã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é èšèŒã®ååç©ã ïŒïŒ äžè¬åŒïŒ åŒäžããã¯åçµååã¯äºéçµåã衚ãããïœã¯
æ°ïŒåã¯ïŒã衚ãããR1ã¯æ°ŽçŽ åååã¯ã¡ãã«
åºã衚ãããR2ã¯ççŽ ååæ°ïŒãïŒã®ã¢ã«ãã«
åºã衚ãããR3ã¯æ°ŽçŽ åååã¯ççŽ ååæ°ïŒã
ïŒã®ïŒâãªããœã¢ã«ãã«åºã衚ããã®ãããã³
ãŒããŸã³èªå°äœã補é ããããã«ã äžè¬åŒ åŒäžãããR1åã³R2ã¯åèšã®ãã®ã衚ãã
ã®ãããã³ãŒããŸã³â21âã¢ã·ã¬ãŒããçžå¿ãã
17âã¢ã·ã¬ãŒãã«å€æããå Žåã«ãã21äœããšã¹
ãã«åããææã®å Žåã¯äžè¬åŒã®Î1,4âã¹ãã
ã€ãã«æ°ŽçŽ æ·»å ããÎ4âã¹ããã€ããšããããš
ãç¹åŸŽãšããæ°èŠãããã³ãŒããŸã³èªå°äœã®è£œ
æ³ã
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3133082.7 | 1981-08-18 | ||
| DE19813133082 DE3133082A1 (de) | 1981-08-18 | 1981-08-18 | Neue hydrocortison-derivate, ihre herstellung und verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5874699A JPS5874699A (ja) | 1983-05-06 |
| JPH033679B2 true JPH033679B2 (ja) | 1991-01-21 |
Family
ID=6139788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57142213A Granted JPS5874699A (ja) | 1981-08-18 | 1982-08-18 | æ°èŠãããã³ãŒããŸã³èªå°äœåã³ãã®è£œæ³ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4435390A (ja) |
| EP (1) | EP0072546B1 (ja) |
| JP (1) | JPS5874699A (ja) |
| AT (1) | ATE16010T1 (ja) |
| DE (2) | DE3133082A1 (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0095894A3 (en) * | 1982-05-31 | 1985-01-02 | Ohta Seiyaku Kabushiki Kaisha. | 6 alpha-methylprednisolone derivatives |
| AU558725B2 (en) * | 1983-09-07 | 1987-02-05 | Mitsubishi Kasei Corporation | Corticoid derivatives |
| DE3344834A1 (de) * | 1983-12-08 | 1985-06-13 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue hydrocortison-und prednisolon-derivate |
| US4810713A (en) * | 1985-12-20 | 1989-03-07 | A. H. Robins Company, Incorporated | Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment |
| DE3637806A1 (de) * | 1986-11-06 | 1988-05-19 | Hoechst Ag | Verfahren zur herstellung von prednisolon-17-ethylcarbonat durch umlagerung von prednisolon-21-ethylcarbonat |
| US5043329A (en) * | 1987-02-17 | 1991-08-27 | Board Of Regents, University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
| US4897260A (en) * | 1987-05-22 | 1990-01-30 | The Rockefeller University | Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same |
| US4959205A (en) * | 1989-03-23 | 1990-09-25 | Collagen Corporation | Composition and method for treatment of dermal inflammation |
| GB9622884D0 (en) * | 1996-11-02 | 1997-01-08 | Duramed Europ Ltd | A method for th e preparation of steroids in the pregene class |
| EP1399463A1 (en) * | 2001-06-18 | 2004-03-24 | PHARMACIA & UPJOHN COMPANY | PROCESS TO PREPARE 11$g(b),17$g(a),21-TRIHYDROXY-6$g(a)-METHYLPREGNA-1,4-DIENE-3,20-DIONE 21-ACETATE |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2897218A (en) | 1956-11-23 | 1959-07-28 | Upjohn Co | 6-methyl-1-dehydro analogues of cortisone, hydrocortisone and 21-esters thereof |
| US3053832A (en) | 1957-04-29 | 1962-09-11 | Schering Corp | Alkylated cortical steroids |
| GB1440063A (en) | 1972-08-11 | 1976-06-23 | Glaxo Lab Ltd | 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids |
| DE2558076C2 (de) * | 1975-12-19 | 1983-12-15 | Schering AG, 1000 Berlin und 4709 Bergkamen | Depot-Steroidester, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische PrÀparate |
| JPS6040439B2 (ja) | 1978-03-29 | 1985-09-11 | 倧æ£è£œè¬æ ªåŒäŒç€Ÿ | ãããã³ã«ããŸã³èªå°äœ |
-
1981
- 1981-08-18 DE DE19813133082 patent/DE3133082A1/de not_active Withdrawn
-
1982
- 1982-08-13 EP EP82107367A patent/EP0072546B1/de not_active Expired
- 1982-08-13 AT AT82107367T patent/ATE16010T1/de not_active IP Right Cessation
- 1982-08-13 DE DE8282107367T patent/DE3266845D1/de not_active Expired
- 1982-08-18 JP JP57142213A patent/JPS5874699A/ja active Granted
- 1982-08-18 US US06/409,263 patent/US4435390A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0072546A1 (de) | 1983-02-23 |
| JPS5874699A (ja) | 1983-05-06 |
| DE3133082A1 (de) | 1983-03-10 |
| ATE16010T1 (de) | 1985-10-15 |
| DE3266845D1 (en) | 1985-11-14 |
| US4435390A (en) | 1984-03-06 |
| EP0072546B1 (de) | 1985-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4587236A (en) | Novel 6α-methylprednisolone derivatives, their preparation, and their use | |
| US4555507A (en) | Novel 6, 16-dimethylcorticoids, their preparation and use | |
| JPH033679B2 (ja) | ||
| GB2130587A (en) | Novel 6a-methylcorticoids and their manufacture and use | |
| GB2070016A (en) | 17-acyloxy-5-corticoids and 17-acyloxy-5-corticoids | |
| US4777165A (en) | 6α, 16β-dimethyl corticoids and their anti-inflammatory use | |
| US4243664A (en) | Novel corticoids | |
| US4912098A (en) | Antiinflammatory 6 alpha-methylhydrocortisones | |
| US4619922A (en) | 6α, 16α-dimethyl corticoids | |
| JPS6129960B2 (ja) | ||
| DE3409554A1 (de) | Neue 6(alpha)-methyl-d-homo-kortikoide | |
| US4330541A (en) | Novel corticoid 17-thioacetals, their preparation and use | |
| CA1144538A (en) | Steroids of the pregnane series substituted in the 17-position, and their manufacture and use | |
| GB1603281A (en) | Derivatives of 9-fluoroprednisolone | |
| CS236900B2 (en) | Processing of 6alpha-methylprednisolon derivatives | |
| JPS60139697A (ja) | ãããã³ãŒããŸã³èªå°äœããã®è£œæ³åã³ã³ã«ãã³ã€ãè£œå€ | |
| JPS6361000B2 (ja) | ||
| KR810000311B1 (ko) | 7-í ë¡-3,20-ëì¥ì-1,4-íë ê·žëëì ë° -4-íë ê·žëšì ì ì¡° ë°©ë² | |
| JPS58132000A (ja) | æ°èŠã³ã«ãã³ã€ãããã®è£œæ³ããã³è©²ååç©ã嫿ãããæçäœçšãæããè£œå€ | |
| JPH0150240B2 (ja) | ||
| DE2809732A1 (de) | Neue derivate des 9-fluorprednisolons | |
| CS244663B2 (cs) | Způsob vÜroby novÜch derivátů 9-chlorprednisolonu |